PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares
This article was originally published in The Pink Sheet Daily
Executive Summary
Waxman will keep pushing for Part D rebates to help fund closing the coverage gap, regardless of PhRMA's proposal for a different discount model. The good news for industry is that "dollars for donuts" remains the formula--and that even Waxman thinks industry will end up getting more than it gives.
You may also be interested in...
Waxman’s Congressional Exclusivity Set To Expire, But There Will Be No Equivalents
Retiring after 40 years in Congress, Waxman leaves an enormous legacy, but also many recent legislative defeats.
Congressmen With Key Health Care Oversight Jurisdiction Named To "Super Committee"
Chairmen from Senate Finance and House Ways and Means and Energy and Commerce will be part of the committee tasked with finding ways to reduce federal spending.
Congressmen With Key Health Care Oversight Jurisdiction Named To "Super Committee"
Chairmen from Senate Finance and House Ways and Means and Energy and Commerce will be part of the committee tasked with finding ways to reduce federal spending.